Coeptis Therapeutics Holdings, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
DeSilva Tara
Director |
Buy | 1,800 @ $0.58 | $1,044 | 32,266 | 01/12/2024 | 01/16/2024 | |
DeSilva Tara
Director |
Buy | 466 @ $0.56 | $261 | 30,466 | 01/12/2024 | 01/16/2024 | |
Cogley Brian
CFO |
Buy | 5,000 @ $0.67 | $3,350 | 30,000 | 01/10/2024 | 01/17/2024 | |
Mehalick David
CEO |
Buy | 14,004 @ $0.66 | $9,243 | 2,782,615 | 01/08/2024 | 01/09/2024 | |
Mehalick David
CEO |
Buy | 6,000 @ $0.67 | $4,020 | 2,768,611 | 01/08/2024 | 01/09/2024 | |
Yerace Daniel Alexander
Director, VP of Operations |
Buy | 10,850 @ $0.69 | $7,487 | 1,071,455 | 01/05/2024 | 01/09/2024 | |
Salkind Gene
Director |
Buy | 11,600 @ $0.69 | $8,004 | 284,056 | 01/05/2024 | 01/09/2024 | |
Mehalick David
CEO |
Buy | 5,050 @ $0.69 | $3,485 | 2,762,611 | 01/05/2024 | 01/09/2024 | |
Cochran Christopher P.
Director |
Buy | 7,000 @ $0.77 | $5,390 | 37,000 | 01/05/2024 | 01/09/2024 | |
Salkind Gene
Director |
Buy | 4,006 @ $1.01 | $4,046 | 4,046 | 08/29/2023 | 08/30/2023 | |
Salkind Gene
Director |
Buy | 28,638 @ $0.91 | $26,061 | 28,638 | 08/25/2023 | 08/30/2023 | |
Calise Chris
Director |
Buy | 2,582 @ $0.94 | $2,419 | 1,464,897 | 08/23/2023 | 08/31/2023 | |
Calise Chris
Director |
Buy | 9,000 @ $0.94 | $8,460 | 1,462,315 | 08/23/2023 | 08/31/2023 |
No record found